The global Benign Prostatic Hyperplasia Surgical Treatment Market size was valued at USD 2,042.94 million in 2024 and is expected to grow at a CAGR of 5.3% The aging male population's growing need for ...

The Five-item Frailty Index (5i-FI) is a tool used by physicians to predict surgical risk and postoperative complications after a procedure. Researchers from Brigham and Women's Hospital, a founding ...

At University of Utah Health, our urologists specialize in helping men achieve better health with top-notch specialty care and the latest advances in treatment and therapies. We provide care for a ...

The holmium laser prostate (HoLEP) surgery is a minimally invasive procedure that treats a condition known as benign prostatic hyperplasia. Although it’s usually considered safe for most people, it ...

En-bloc and 2-lobe techniques may offer efficiency benefits but do not result in improvements in postoperative outcomes. (HealthDay News) — For patients undergoing Thulium laser enucleation of the ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Congenital Adrenal Hyperplasia pipeline constitutes 5+ key companies continuously working towards ...